REQUEST A DEMO
Total
USD $0.00
Search more companies

U2Bio Co. Ltd. (South Korea)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: U2Bio Co. Ltd. Profile Updated: August 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

U2Bio Co. Ltd. is a company based in South Korea, with its head office in Seoul. It operates in the Biological Product (except Diagnostic) Manufacturing industry. The enterprise was incorporated on August 27, 2026. 98 (2025) employees currently work for U2Bio Co. Ltd.. The latest financial highlights indicate a net sales revenue increase of 24.16% in Q12026. Over the same period, its total assets grew by 50.15%. In 2026, U2Bio Co. Ltd.’s net profit margin decreased by 1.28%.

Headquarters
65, Geoma-Ro, Songpa-Gu
Seoul; Seoul;

Contact Details: Purchase the U2Bio Co. Ltd. report to view the information.

Website: http://www.u2bio.co.kr

Basic Information
Total Employees:
Purchase the U2Bio Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the U2Bio Co. Ltd. report to view the information.
Financial Auditors:
Purchase the U2Bio Co. Ltd. report to view the information.
Incorporation Date:
August 27, 2026
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)유투바이오
Company Performance
Financial values in the chart are available after U2Bio Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
24.16%
Total Operating Revenue
24.63%
Operating Profit
-188.91%
EBITDA
-134.02%
Net Profit/Loss for the Period
-60.26%
Total Assets
50.15%
Total Equity
57.82%
Operating Profit Margin
-13.05%
Net Profit Margin
-1.28%
Return on Equity (ROE)
-0.01%
Debt / Equity
-0.43%
Quick Ratio
-2.81%
Cash Ratio
1.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?